BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Darin N, Oldfors A, Moslemi A, Holme E, Tulinius M. The incidence of mitochondrial encephalomyopathies in childhood: Clinical features and morphological, biochemical, and DNA abnormalities. Ann Neurol 2001;49:377-83. [DOI: 10.1002/ana.75] [Cited by in Crossref: 207] [Cited by in F6Publishing: 107] [Article Influence: 9.9] [Reference Citation Analysis]
Number Citing Articles
1 Uusimaa J, Moilanen JS, Vainionpää L, Tapanainen P, Lindholm P, Nuutinen M, Löppönen T, Mäki-Torkko E, Rantala H, Majamaa K. Prevalence, segregation, and phenotype of the mitochondrial DNA 3243A>G mutation in children. Ann Neurol 2007;62:278-87. [PMID: 17823937 DOI: 10.1002/ana.21196] [Cited by in Crossref: 64] [Cited by in F6Publishing: 55] [Article Influence: 4.3] [Reference Citation Analysis]
2 Savvidou A, Ivarsson L, Naess K, Eklund EA, Lundgren J, Dahlin M, Frithiof D, Sofou K, Darin N. Novel imaging findings in pyruvate dehydrogenase complex (PDHc) deficiency-Results from a nationwide population-based study. J Inherit Metab Dis 2021. [PMID: 34873726 DOI: 10.1002/jimd.12463] [Reference Citation Analysis]
3 Halperin D, Drabkin M, Wormser O, Yogev Y, Dolgin V, Shorer Z, Gradstein L, Shelef I, Flusser H, Birk OS. Phenotypic variability and mutation hotspot in COX15-related Leigh syndrome. Am J Med Genet A 2020;182:1506-12. [PMID: 32232962 DOI: 10.1002/ajmg.a.61577] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
4 Sofou K, Steneryd K, Wiklund L, Tulinius M, Darin N. MRI of the brain in childhood-onset mitochondrial disorders with central nervous system involvement. Mitochondrion 2013;13:364-71. [DOI: 10.1016/j.mito.2013.04.008] [Cited by in Crossref: 27] [Cited by in F6Publishing: 22] [Article Influence: 3.0] [Reference Citation Analysis]
5 Brunel-guitton C, Levtova A, Sasarman F. Mitochondrial Diseases and Cardiomyopathies. Canadian Journal of Cardiology 2015;31:1360-76. [DOI: 10.1016/j.cjca.2015.08.017] [Cited by in Crossref: 40] [Cited by in F6Publishing: 28] [Article Influence: 5.7] [Reference Citation Analysis]
6 Thorburn DR, Dahl HM, Singh KK. The pros and cons of mitochondrial manipulation in the human germ line. Mitochondrion 2001;1:123-7. [DOI: 10.1016/s1567-7249(01)00013-7] [Cited by in Crossref: 11] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
7 Thorburn DR. Mitochondrial disorders: Prevalence, myths and advances. J Inherit Metab Dis 2004;27:349-62. [DOI: 10.1023/b:boli.0000031098.41409.55] [Cited by in Crossref: 157] [Cited by in F6Publishing: 65] [Article Influence: 8.7] [Reference Citation Analysis]
8 Masri A, Wahsh SA. Manifestations and treatment of epilepsy in children with neurometabolic disorders: a series from Jordan. Seizure 2014;23:10-5. [PMID: 23998926 DOI: 10.1016/j.seizure.2013.08.006] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
9 Davis RL, Liang C, Sue CM. Mitochondrial diseases. Neurogenetics, Part I. Elsevier; 2018. pp. 125-41. [DOI: 10.1016/b978-0-444-63233-3.00010-5] [Cited by in Crossref: 14] [Cited by in F6Publishing: 2] [Article Influence: 3.5] [Reference Citation Analysis]
10 Chen L, Cui Y, Jiang D, Ma C, Tse H, Hwu W, Lian Q. Management of Leigh syndrome: Current status and new insights. Clinical Genetics 2018;93:1131-40. [DOI: 10.1111/cge.13139] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
11 Yatsuga S, Povalko N, Nishioka J, Katayama K, Kakimoto N, Matsuishi T, Kakuma T, Koga Y; Taro Matsuoka for MELAS Study Group in Japan. MELAS: a nationwide prospective cohort study of 96 patients in Japan. Biochim Biophys Acta. 2012;1820:619-624. [PMID: 21443929 DOI: 10.1016/j.bbagen.2011.03.015] [Cited by in Crossref: 127] [Cited by in F6Publishing: 105] [Article Influence: 11.5] [Reference Citation Analysis]
12 Jin T, Shen H, Zhao Z, Hu J. Clinical, pathological, and neuroimaging analyses of two cases of Leigh syndrome in a Chinese family. J Child Neurol 2014;29:NP143-8. [PMID: 24413359 DOI: 10.1177/0883073813512524] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
13 Chinnery PF, Bindoff LA; Europen neuromuscular center. 116th ENMC international workshop: the treatment of mitochondrial disorders, 14th-16th March 2003, Naarden, The Netherlands. Neuromuscul Disord 2003;13:757-64. [PMID: 14561500 DOI: 10.1016/s0960-8966(03)00097-x] [Cited by in Crossref: 27] [Cited by in F6Publishing: 3] [Article Influence: 1.4] [Reference Citation Analysis]
14 Sofou K. Mitochondrial disease: a challenge for the caregiver, the family, and society. J Child Neurol 2013;28:663-7. [PMID: 23529909 DOI: 10.1177/0883073813481622] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
15 Ostergaard E, Hansen FJ, Sorensen N, Duno M, Vissing J, Larsen PL, Faeroe O, Thorgrimsson S, Wibrand F, Christensen E, Schwartz M. Mitochondrial encephalomyopathy with elevated methylmalonic acid is caused by SUCLA2 mutations. Brain 2007;130:853-61. [DOI: 10.1093/brain/awl383] [Cited by in Crossref: 129] [Cited by in F6Publishing: 114] [Article Influence: 8.6] [Reference Citation Analysis]
16 Chinnery PF. New approaches to the treatment of mitochondrial disorders. Reprod Biomed Online 2004;8:16-23. [PMID: 14759282 DOI: 10.1016/s1472-6483(10)60494-4] [Cited by in Crossref: 13] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
17 Kang PB, Hunter JV, Melvin JJ, Selak MA, Faerber EN, Kaye EM. Infantile Leukoencephalopathy Owing to Mitochondrial Enzyme Dysfunction. J Child Neurol 2002;17:421-8. [DOI: 10.1177/088307380201700605] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
18 Castro-gago M, Blanco-barca MO, Campos-gonzález Y, Arenas-barbero J, Pintos-martínez E, Eirís-puñal J. Epidemiology of Pediatric Mitochondrial Respiratory Chain Disorders in Northwest Spain. Pediatric Neurology 2006;34:204-11. [DOI: 10.1016/j.pediatrneurol.2005.07.011] [Cited by in Crossref: 30] [Cited by in F6Publishing: 25] [Article Influence: 1.9] [Reference Citation Analysis]
19 Soler-alfonso C, Enns GM, Koenig MK, Saavedra H, Bonfante-mejia E, Northrup H. Identification of HIBCH Gene Mutations Causing Autosomal Recessive Leigh Syndrome: A Gene Involved in Valine Metabolism. Pediatric Neurology 2015;52:361-5. [DOI: 10.1016/j.pediatrneurol.2014.10.023] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 3.1] [Reference Citation Analysis]
20 Davidzon G, Mancuso M, Ferraris S, Quinzii C, Hirano M, Peters HL, Kirby D, Thorburn DR, DiMauro S. POLG mutations and Alpers syndrome. Ann Neurol. 2005;57:921-923. [PMID: 15929042 DOI: 10.1002/ana.20498] [Cited by in Crossref: 85] [Cited by in F6Publishing: 74] [Article Influence: 5.0] [Reference Citation Analysis]
21 Uysal F, Cakmakçı H, Yiş U, Ellidokuz H, Hız AS. Measurement of the apparent diffusion coefficient in paediatric mitochondrial encephalopathy cases and a comparison of parenchymal changes associated with the disease using follow-up diffusion coefficient measurements. Eur J Radiol 2014;83:212-8. [PMID: 24176530 DOI: 10.1016/j.ejrad.2013.06.031] [Reference Citation Analysis]
22 Gillis LA, Sokol RJ. Gastrointestinal manifestations of mitochondrial disease. Gastroenterol Clin North Am 2003;32:789-817, v. [PMID: 14562575 DOI: 10.1016/s0889-8553(03)00052-9] [Cited by in Crossref: 23] [Cited by in F6Publishing: 9] [Article Influence: 1.2] [Reference Citation Analysis]
23 Lim AZ, Ng YS, Blain A, Jiminez-Moreno C, Alston CL, Nesbitt V, Simmons L, Santra S, Wassmer E, Blakely EL, Turnbull DM, Taylor RW, Gorman GS, McFarland R. Natural History of Leigh Syndrome: A Study of Disease Burden and Progression. Ann Neurol 2021. [PMID: 34716721 DOI: 10.1002/ana.26260] [Reference Citation Analysis]
24 Vladutiu GD. Laboratory diagnosis of metabolic myopathies. Muscle Nerve 2002;25:649-63. [DOI: 10.1002/mus.10104] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 0.6] [Reference Citation Analysis]
25 Shah NS, Mitchell WG, Boles RG. Mitochondrial Disorders: A Potentially Under-recognized Etiology of Infantile Spasms. J Child Neurol 2002;17:369-72. [DOI: 10.1177/088307380201700511] [Cited by in Crossref: 27] [Cited by in F6Publishing: 24] [Article Influence: 4.5] [Reference Citation Analysis]
26 Sharrard M. Clinical presentation of mitochondrial diseases in children with progressive intellectual and neurological deterioration. Developmental Medicine & Child Neurology 2010;52:407-8. [DOI: 10.1111/j.1469-8749.2009.03488.x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
27 Yuan JH, Sakiyama Y, Higuchi I, Inamori Y, Higuchi Y, Hashiguchi A, Higashi K, Yoshimura A, Takashima H. Mitochondrial myopathy with autophagic vacuoles in patients with the m.8344A>G mutation. J Clin Pathol 2013;66:659-64. [PMID: 23559353 DOI: 10.1136/jclinpath-2012-201431] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.2] [Reference Citation Analysis]
28 Gopan A, Sarma MS. Mitochondrial hepatopathy: Respiratory chain disorders- ‘breathing in and out of the liver’. World J Hepatol 2021; 13(11): 1707-1726 [PMID: 34904040 DOI: 10.4254/wjh.v13.i11.1707] [Reference Citation Analysis]
29 Gorman GS, Chinnery PF, DiMauro S, Hirano M, Koga Y, McFarland R, Suomalainen A, Thorburn DR, Zeviani M, Turnbull DM. Mitochondrial diseases. Nat Rev Dis Primers 2016;2:16080. [PMID: 27775730 DOI: 10.1038/nrdp.2016.80] [Cited by in Crossref: 475] [Cited by in F6Publishing: 411] [Article Influence: 79.2] [Reference Citation Analysis]
30 Galbiati S, Bordoni A, Papadimitriou D, Toscano A, Rodolico C, Katsarou E, Sciacco M, Garufi A, Prelle A, Aguennouz M', Bonsignore M, Crimi M, Martinuzzi A, Bresolin N, Papadimitriou A, Comi GP. New mutations in TK2 gene associated with mitochondrial DNA depletion. Pediatr Neurol 2006;34:177-85. [PMID: 16504786 DOI: 10.1016/j.pediatrneurol.2005.07.013] [Cited by in Crossref: 50] [Cited by in F6Publishing: 45] [Article Influence: 3.1] [Reference Citation Analysis]
31 Cloots K, Verbeek J, Orlent H, Meersseman W, Cassiman D. Mitochondrial hepatopathy in adults: a case series and review of the literature. Eur J Gastroenterol Hepatol 2013;25:892-8. [PMID: 23426270 DOI: 10.1097/MEG.0b013e32835ee629] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
32 Menezes MP, Ouvrier RA. Peripheral neuropathy associated with mitochondrial disease in children. Dev Med Child Neurol 2012;54:407-14. [PMID: 22435634 DOI: 10.1111/j.1469-8749.2012.04271.x] [Cited by in Crossref: 26] [Cited by in F6Publishing: 20] [Article Influence: 2.6] [Reference Citation Analysis]
33 Chinnery PF, DiMauro S. Mitochondrial hepatopathies. J Hepatol 2005;43:207-9. [PMID: 15964657 DOI: 10.1016/j.jhep.2005.05.012] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 0.9] [Reference Citation Analysis]
34 Fato R, Bergamini C, Leoni S, Strocchi P, Lenaz G. Generation of Reactive Oxygen Species by Mitochondrial Complex I: Implications in Neurodegeneration. Neurochem Res 2008;33:2487-501. [DOI: 10.1007/s11064-008-9747-0] [Cited by in Crossref: 61] [Cited by in F6Publishing: 57] [Article Influence: 4.4] [Reference Citation Analysis]
35 Lim A, Thomas RH. The mitochondrial epilepsies. European Journal of Paediatric Neurology 2020;24:47-52. [DOI: 10.1016/j.ejpn.2019.12.021] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
36 Comi GP, Strazzer S, Galbiati S, Bresolin N. Cytochrome c oxidase deficiency. Int Rev Neurobiol 2002;53:205-40. [PMID: 12512342 DOI: 10.1016/s0074-7742(02)53009-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
37 Baide-mairena H, Gaudó P, Marti-sánchez L, Emperador S, Sánchez-montanez A, Alonso-luengo O, Correa M, Grau AM, Ortigoza-escobar JD, Artuch R, Vázquez E, Del Toro M, Garrido-pérez N, Ruiz-pesini E, Montoya J, Bayona-bafaluy MP, Pérez-dueñas B. Mutations in the mitochondrial complex I assembly factor NDUFAF6 cause isolated bilateral striatal necrosis and progressive dystonia in childhood. Molecular Genetics and Metabolism 2019;126:250-8. [DOI: 10.1016/j.ymgme.2019.01.001] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
38 Rahman S. Mitochondrial disease in children. J Intern Med 2020;287:609-33. [PMID: 32176382 DOI: 10.1111/joim.13054] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 7.5] [Reference Citation Analysis]
39 Gonçalves FG, Alves CAPF, Heuer B, Peterson J, Viaene AN, Reis Teixeira S, Martín-Saavedra JS, Andronikou S, Goldstein A, Vossough A. Primary Mitochondrial Disorders of the Pediatric Central Nervous System: Neuroimaging Findings. Radiographics 2020;40:2042-67. [PMID: 33136487 DOI: 10.1148/rg.2020200052] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
40 Piekutowska-abramczuk D, Popowska E, Pronicki M, Karczmarewicz E, Tylek-lemanska D, Sykut-cegielska J, Szymanska-dembinska T, Bielecka L, Krajewska-walasek M, Pronicka E. High prevalence of SURF1 c.845_846delCT mutation in Polish Leigh patients. European Journal of Paediatric Neurology 2009;13:146-53. [DOI: 10.1016/j.ejpn.2008.03.009] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.1] [Reference Citation Analysis]
41 Eom S, Lee YM. In Reply: Death in Pediatric Mitochondrial Disorders. Pediatr Neurol 2017;73:e3. [PMID: 28583703 DOI: 10.1016/j.pediatrneurol.2017.05.004] [Reference Citation Analysis]
42 Finsterer J, Zarrouk-Mahjoub S, Shoffner JM. MERRF Classification: Implications for Diagnosis and Clinical Trials. Pediatr Neurol 2018;80:8-23. [PMID: 29449072 DOI: 10.1016/j.pediatrneurol.2017.12.005] [Cited by in Crossref: 30] [Cited by in F6Publishing: 18] [Article Influence: 6.0] [Reference Citation Analysis]
43 Baiker K, Hofmann S, Fischer A, Gödde T, Medl S, Schmahl W, Bauer MF, Matiasek K. Leigh-like subacute necrotising encephalopathy in Yorkshire Terriers: neuropathological characterisation, respiratory chain activities and mitochondrial DNA. Acta Neuropathol 2009;118:697-709. [PMID: 19466433 DOI: 10.1007/s00401-009-0548-6] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.0] [Reference Citation Analysis]
44 Chi CS. Diagnostic approach in infants and children with mitochondrial diseases. Pediatr Neonatol 2015;56:7-18. [PMID: 25151629 DOI: 10.1016/j.pedneo.2014.03.009] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
45 Liu CS, Cheng WL, Chen YY, Ma YS, Pang CY, Wei YH. High prevalence of the COII/tRNA(Lys) intergenic 9-bp deletion in mitochondrial DNA of Taiwanese patients with MELAS or MERRF syndrome. Ann N Y Acad Sci 2005;1042:82-7. [PMID: 15965049 DOI: 10.1196/annals.1338.058] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
46 Benhammou V, Tardieu M, Warszawski J, Rustin P, Blanche S; on behalf of the French Perinatal Cohort. Clinical mitochondrial dysfunction in uninfected children born to HIV-infected mothers following perinatal exposure to nucleoside analogues. Environ Mol Mutagen 2007;48:173-8. [DOI: 10.1002/em.20279] [Cited by in Crossref: 25] [Cited by in F6Publishing: 18] [Article Influence: 1.7] [Reference Citation Analysis]
47 Moslemi A, Darin N. Molecular genetic and clinical aspects of mitochondrial disorders in childhood. Mitochondrion 2007;7:241-52. [DOI: 10.1016/j.mito.2007.02.002] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 1.8] [Reference Citation Analysis]
48 Delonlay P, Rötig A, Sarnat HB. Respiratory chain deficiencies. Pediatric Neurology Part III. Elsevier; 2013. pp. 1651-66. [DOI: 10.1016/b978-0-444-59565-2.00033-2] [Cited by in Crossref: 16] [Cited by in F6Publishing: 4] [Article Influence: 1.8] [Reference Citation Analysis]
49 Esteitie N, Hinttala R, Wibom R, Nilsson H, Hance N, Naess K, Teär-Fahnehjelm K, von Döbeln U, Majamaa K, Larsson NG. Secondary metabolic effects in complex I deficiency. Ann Neurol 2005;58:544-52. [PMID: 16044424 DOI: 10.1002/ana.20570] [Cited by in Crossref: 39] [Cited by in F6Publishing: 33] [Article Influence: 2.3] [Reference Citation Analysis]
50 Chinnery PF. Inheritance of mitochondrial disorders. Mitochondrion 2002;2:149-55. [DOI: 10.1016/s1567-7249(02)00046-6] [Cited by in Crossref: 18] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
51 Borisov VB. Defects in mitochondrial respiratory complexes III and IV, and human pathologies. Mol Aspects Med 2002;23:385-412. [PMID: 12231008 DOI: 10.1016/s0098-2997(02)00013-4] [Cited by in Crossref: 29] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
52 Chinnery P, Majamaa K, Turnbull D, Thorburn D. Treatment for mitochondrial disorders. Cochrane Database Syst Rev 2006;:CD004426. [PMID: 16437486 DOI: 10.1002/14651858.CD004426.pub2] [Cited by in Crossref: 31] [Cited by in F6Publishing: 33] [Article Influence: 1.9] [Reference Citation Analysis]
53 Srinivas Bharath MM. Post-Translational Oxidative Modifications of Mitochondrial Complex I (NADH: Ubiquinone Oxidoreductase): Implications for Pathogenesis and Therapeutics in Human Diseases. J Alzheimers Dis 2017;60:S69-86. [PMID: 28582861 DOI: 10.3233/JAD-170117] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
54 DiMauro S. Mitochondrial DNA medicine. Biosci Rep 2007;27:5-9. [PMID: 17484047 DOI: 10.1007/s10540-007-9032-5] [Cited by in Crossref: 28] [Cited by in F6Publishing: 24] [Article Influence: 1.9] [Reference Citation Analysis]
55 Oyarzabal A, Marin-Valencia I. Synaptic energy metabolism and neuronal excitability, in sickness and health. J Inherit Metab Dis 2019;42:220-36. [PMID: 30734319 DOI: 10.1002/jimd.12071] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 7.0] [Reference Citation Analysis]
56 Silva JP, Larsson NG. Manipulation of mitochondrial DNA gene expression in the mouse. Biochim Biophys Acta 2002;1555:106-10. [PMID: 12206900 DOI: 10.1016/s0005-2728(02)00263-3] [Cited by in Crossref: 21] [Cited by in F6Publishing: 11] [Article Influence: 1.1] [Reference Citation Analysis]
57 Amai T, Tsuji T, Ueda M, Kuroda K. Development of a mito-CRISPR system for generating mitochondrial DNA-deleted strain in Saccharomyces cerevisiae. Biosci Biotechnol Biochem 2021;85:895-901. [PMID: 33580687 DOI: 10.1093/bbb/zbaa119] [Reference Citation Analysis]
58 Barret B, Tardieu M, Rustin P, Lacroix C, Chabrol B, Desguerre I, Dollfus C, Mayaux M, Blanche S. Persistent mitochondrial dysfunction in HIV-1-exposed but uninfected infants: clinical screening in a large prospective cohort. AIDS 2003;17:1769-85. [DOI: 10.1097/00002030-200308150-00006] [Cited by in Crossref: 195] [Cited by in F6Publishing: 151] [Article Influence: 10.3] [Reference Citation Analysis]
59 Remenyi V, Inczedy-Farkas G, Komlosi K, Horvath R, Maasz A, Janicsek I, Pentelenyi K, Gal A, Karcagi V, Melegh B, Molnar MJ. Retrospective assessment of the most common mitochondrial DNA mutations in a large Hungarian cohort of suspect mitochondrial cases. Mitochondrial DNA 2015;26:572-8. [PMID: 24438288 DOI: 10.3109/19401736.2013.878901] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
60 Martinelli D, Catteruccia M, Piemonte F, Pastore A, Tozzi G, Dionisi-vici C, Pontrelli G, Corsetti T, Livadiotti S, Kheifets V, Hinman A, Shrader WD, Thoolen M, Klein MB, Bertini E, Miller G. EPI-743 reverses the progression of the pediatric mitochondrial disease—Genetically defined Leigh Syndrome. Molecular Genetics and Metabolism 2012;107:383-8. [DOI: 10.1016/j.ymgme.2012.09.007] [Cited by in Crossref: 122] [Cited by in F6Publishing: 112] [Article Influence: 12.2] [Reference Citation Analysis]
61 Venhoff N, Walker UA. Mitochondrial disease in the offspring as a result of antiretroviral therapy. Expert Opin Drug Saf 2006;5:373-81. [PMID: 16610967 DOI: 10.1517/14740338.5.3.373] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 1.0] [Reference Citation Analysis]
62 Parikh S, Galioto R, Lapin B, Haas R, Hirano M, Koenig MK, Saneto RP, Zolkipli-cunningham Z, Goldstein A, Karaa A. Fatigue in primary genetic mitochondrial disease: No rest for the weary. Neuromuscular Disorders 2019;29:895-902. [DOI: 10.1016/j.nmd.2019.09.012] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
63 Saneto RP. Genetics of Mitochondrial Disease. Adv Genet 2017;98:63-116. [PMID: 28942795 DOI: 10.1016/bs.adgen.2017.06.002] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
64 Angural A, Sharma I, Pandoh P, Sharma V, Spolia A, Rai E, Singh V, Razdan S, Pandita KK, Sharma S. A case report on a novel MT-ATP6 gene variation in atypical mitochondrial Leigh syndrome associated with bilateral basal ganglia calcifications. Mitochondrion 2019;46:209-13. [PMID: 29929013 DOI: 10.1016/j.mito.2018.06.005] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
65 Sofou K, Shahim P, Tulinius M, Blennow K, Zetterberg H, Mattsson N, Darin N. Cerebrospinal fluid neurofilament light is associated with survival in mitochondrial disease patients. Mitochondrion 2019;46:228-35. [PMID: 30004022 DOI: 10.1016/j.mito.2018.07.002] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
66 Rizza T, Vazquez-Memije ME, Meschini MC, Bianchi M, Tozzi G, Nesti C, Piemonte F, Bertini E, Santorelli FM, Carrozzo R. Assaying ATP synthesis in cultured cells: a valuable tool for the diagnosis of patients with mitochondrial disorders. Biochem Biophys Res Commun 2009;383:58-62. [PMID: 19332025 DOI: 10.1016/j.bbrc.2009.03.121] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 1.7] [Reference Citation Analysis]
67 Oldfors A, Tulinius M. Mitochondrial encephalomyopathies. Myopathies. Elsevier; 2007. pp. 125-65. [DOI: 10.1016/s0072-9752(07)86006-4] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
68 Volpe JJ. Neuromuscular Disorders: Muscle Involvement and Restricted Disorders. Neurology of the Newborn. Elsevier; 2008. pp. 801-48. [DOI: 10.1016/b978-1-4160-3995-2.10019-6] [Cited by in Crossref: 5] [Article Influence: 0.4] [Reference Citation Analysis]
69 Pilch J, Asman M, Jamroz E, Kajor M, Kotrys-puchalska E, Goss M, Krzak M, Witecka J, Gmiński J, Sieroń AL. Surveyor Nuclease Detection of Mutations and Polymorphisms of mtDNA in Children. Pediatric Neurology 2010;43:325-30. [DOI: 10.1016/j.pediatrneurol.2010.05.023] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
70 Alves CAPF, Gonçalves FG, Grieb D, Lucato LT, Goldstein AC, Zuccoli G. Neuroimaging of Mitochondrial Cytopathies. Topics in Magnetic Resonance Imaging 2018;27:219-40. [DOI: 10.1097/rmr.0000000000000173] [Cited by in Crossref: 2] [Article Influence: 0.5] [Reference Citation Analysis]
71 Freisinger P, Horvath R, Macmillan C, Peters J, Jaksch M. Reversion of hypertrophic cardiomyopathy in a patient with deficiency of the mitochondrial copper binding protein Sco2: Is there a potential effect of copper? J Inherit Metab Dis 2004;27:67-79. [DOI: 10.1023/b:boli.0000016614.47380.2f] [Cited by in Crossref: 44] [Cited by in F6Publishing: 17] [Article Influence: 2.4] [Reference Citation Analysis]
72 Schaefer AM, Taylor RW, Turnbull DM, Chinnery PF. The epidemiology of mitochondrial disorders--past, present and future. Biochim Biophys Acta. 2004;1659:115-120. [PMID: 15576042 DOI: 10.1016/j.bbabio.2004.09.005] [Cited by in Crossref: 253] [Cited by in F6Publishing: 221] [Article Influence: 14.9] [Reference Citation Analysis]
73 Federico A, Cardaioli E, Da Pozzo P, Formichi P, Gallus GN, Radi E. Mitochondria, oxidative stress and neurodegeneration. J Neurol Sci. 2012;322:254-262. [PMID: 22669122 DOI: 10.1016/j.jns.2012.05.030] [Cited by in Crossref: 441] [Cited by in F6Publishing: 413] [Article Influence: 44.1] [Reference Citation Analysis]
74 Borchert A, Wolf NI, Wilichowski E. Current concepts of mitochondrial disorders in childhood. Semin Pediatr Neurol 2002;9:151-9. [PMID: 12138999 DOI: 10.1053/spen.2002.33800] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
75 Blanche S, Tardieu M, Benhammou V, Warszawski J, Rustin P. Mitochondrial dysfunction following perinatal exposure to nucleoside analogues. AIDS 2006;20:1685-90. [PMID: 16931932 DOI: 10.1097/01.aids.0000242814.42344.77] [Cited by in Crossref: 52] [Cited by in F6Publishing: 46] [Article Influence: 3.5] [Reference Citation Analysis]
76 Marcus KA, Barends M, Morava-kozicz E, Feuth T, de Korte CL, Kapusta L. Early detection of myocardial dysfunction in children with mitochondrial disease: An ultrasound and two-dimensional strain echocardiography study. Mitochondrion 2011;11:405-12. [DOI: 10.1016/j.mito.2010.12.005] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.2] [Reference Citation Analysis]
77 Louw R, Smuts I, Wilsenach KL, Jonck LM, Schoonen M, van der Westhuizen FH. The dilemma of diagnosing coenzyme Q10 deficiency in muscle. Mol Genet Metab 2018;125:38-43. [PMID: 29530532 DOI: 10.1016/j.ymgme.2018.02.015] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
78 Vanderver A. Tools for diagnosis of leukodystrophies and other disorders presenting with white matter disease. Curr Neurol Neurosci Rep 2005;5:110-8. [DOI: 10.1007/s11910-005-0008-1] [Cited by in Crossref: 15] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
79 Schapira AH. Mitochondrial disease. Lancet 2006;368:70-82. [PMID: 16815381 DOI: 10.1016/S0140-6736(06)68970-8] [Cited by in Crossref: 413] [Cited by in F6Publishing: 165] [Article Influence: 25.8] [Reference Citation Analysis]
80 Gowthami N, Sunitha B, Kumar M, Keshava Prasad T, Gayathri N, Padmanabhan B, Srinivas Bharath M. Mapping the protein phosphorylation sites in human mitochondrial complex I (NADH: Ubiquinone oxidoreductase): A bioinformatics study with implications for brain aging and neurodegeneration. Journal of Chemical Neuroanatomy 2019;95:13-28. [DOI: 10.1016/j.jchemneu.2018.02.004] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
81 Rantamäki MT, Soini HK, Finnilä SM, Majamaa K, Udd B. Adult-onset ataxia and polyneuropathy caused by mitochondrial 8993T→C mutation. Ann Neurol 2005;58:337-40. [DOI: 10.1002/ana.20555] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 1.2] [Reference Citation Analysis]
82 Björkman K, Vissing J, Østergaard E, Bindoff LA, de Coo IFM, Engvall M, Hikmat O, Isohanni P, Kollberg G, Lindberg C, Majamaa K, Naess K, Uusimaa J, Tulinius M, Darin N. Phenotypic spectrum and clinical course of single large-scale mitochondrial DNA deletion disease in the paediatric population: a multicentre study. J Med Genet 2021:jmedgenet-2021-108006. [PMID: 34872991 DOI: 10.1136/jmedgenet-2021-108006] [Reference Citation Analysis]
83 Brunetti-Pierri N, Pignatelli R, Fouladi N, Towbin JA, Belmont JW, Craigen WJ, Wong LJ, Jefferies JL, Scaglia F. Dilation of the aortic root in mitochondrial disease patients. Mol Genet Metab. 2011;103:167-170. [PMID: 21406331 DOI: 10.1016/j.ymgme.2011.02.007] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 1.8] [Reference Citation Analysis]
84 Vanderver A, Gropman AL. Childhood Mitochondrial Disorders and Other Inborn Errors of Metabolism Presenting With White Matter Disease. In: Broderick PA, Rahni DN, Kolodny EH, editors. Bioimaging in Neurodegeneration. Totowa: Humana Press; 2005. pp. 261-96. [DOI: 10.1007/978-1-59259-888-5_22] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
85 Sofou K, Moslemi AR, Kollberg G, Bjarnadóttir I, Oldfors A, Nennesmo I, Holme E, Tulinius M, Darin N. Phenotypic and genotypic variability in Alpers syndrome. Eur J Paediatr Neurol 2012;16:379-89. [PMID: 22237560 DOI: 10.1016/j.ejpn.2011.12.006] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 1.8] [Reference Citation Analysis]
86 Haginoya K, Kaneta T, Togashi N, Hino-Fukuyo N, Kobayashi T, Uematsu M, Kitamura T, Inui T, Okubo Y, Takezawa Y, Anzai M, Endo W, Miyake N, Saitsu H, Matsumoto N, Kure S. FDG-PET study of patients with Leigh syndrome. J Neurol Sci 2016;362:309-13. [PMID: 26944169 DOI: 10.1016/j.jns.2016.02.008] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.7] [Reference Citation Analysis]
87 Lerman-sagie T, Leshinsky-silver E, Watemberg N, Luckman Y, Lev D. White matter involvement in mitochondrial diseases. Molecular Genetics and Metabolism 2005;84:127-36. [DOI: 10.1016/j.ymgme.2004.09.008] [Cited by in Crossref: 63] [Cited by in F6Publishing: 57] [Article Influence: 3.7] [Reference Citation Analysis]
88 Miyauchi A, Osaka H, Nagashima M, Kuwajima M, Monden Y, Kohda M, Kishita Y, Okazaki Y, Murayama K, Ohtake A, Yamagata T. Leigh syndrome with spinal cord involvement due to a hemizygous NDUFA1 mutation. Brain Dev 2018;40:498-502. [PMID: 29506883 DOI: 10.1016/j.braindev.2018.02.007] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
89 Sonam K, Bindu PS, Srinivas Bharath MM, Govindaraj P, Gayathri N, Arvinda HR, Chiplunkar S, Nagappa M, Sinha S, Khan NA, Nunia V, Paramasivam A, Thangaraj K, Taly AB. Mitochondrial oxidative phosphorylation disorders in children: Phenotypic, genotypic and biochemical correlations in 85 patients from South India. Mitochondrion 2017;32:42-9. [PMID: 27826120 DOI: 10.1016/j.mito.2016.11.002] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
90 Bockaert J, Marin P. mTOR in Brain Physiology and Pathologies. Physiol Rev 2015;95:1157-87. [PMID: 26269525 DOI: 10.1152/physrev.00038.2014] [Cited by in Crossref: 158] [Cited by in F6Publishing: 157] [Article Influence: 22.6] [Reference Citation Analysis]
91 Darin N, Kollberg G, Moslemi AR, Tulinius M, Holme E, Grönlund MA, Andersson S, Oldfors A. Mitochondrial myopathy with exercise intolerance and retinal dystrophy in a sporadic patient with a G583A mutation in the mt tRNA(phe) gene. Neuromuscul Disord 2006;16:504-6. [PMID: 16806928 DOI: 10.1016/j.nmd.2006.05.010] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 0.7] [Reference Citation Analysis]
92 Eom S, Lee HN, Lee S, Kang H, Lee JS, Kim HD, Lee Y. Cause of Death in Children With Mitochondrial Diseases. Pediatric Neurology 2017;66:82-8. [DOI: 10.1016/j.pediatrneurol.2016.10.006] [Cited by in Crossref: 21] [Cited by in F6Publishing: 15] [Article Influence: 4.2] [Reference Citation Analysis]
93 Skladal D, Sudmeier C, Konstantopoulou V, Stöckler-Ipsiroglu S, Plecko-Startinig B, Bernert G, Zeman J, Sperl W. The clinical spectrum of mitochondrial disease in 75 pediatric patients. Clin Pediatr (Phila) 2003;42:703-10. [PMID: 14601919 DOI: 10.1177/000992280304200806] [Cited by in Crossref: 37] [Cited by in F6Publishing: 37] [Article Influence: 2.1] [Reference Citation Analysis]
94 Lerman J. Perioperative management of the paediatric patient with coexisting neuromuscular disease. Br J Anaesth 2011;107 Suppl 1:i79-89. [PMID: 22156273 DOI: 10.1093/bja/aer335] [Cited by in Crossref: 48] [Cited by in F6Publishing: 19] [Article Influence: 4.8] [Reference Citation Analysis]
95 Naess K, Freyer C, Bruhn H, Wibom R, Malm G, Nennesmo I, von Döbeln U, Larsson NG. MtDNA mutations are a common cause of severe disease phenotypes in children with Leigh syndrome. Biochim Biophys Acta 2009;1787:484-90. [PMID: 19103152 DOI: 10.1016/j.bbabio.2008.11.014] [Cited by in Crossref: 31] [Cited by in F6Publishing: 31] [Article Influence: 2.2] [Reference Citation Analysis]
96 Arpa J, Cruz-Martínez A, Campos Y, Gutiérrez-Molina M, García-Rio F, Pérez-Conde C, Martín MA, Rubio JC, Del Hoyo P, Arpa-Fernández A, Arenas J. Prevalence and progression of mitochondrial diseases: a study of 50 patients. Muscle Nerve 2003;28:690-5. [PMID: 14639582 DOI: 10.1002/mus.10507] [Cited by in Crossref: 28] [Cited by in F6Publishing: 17] [Article Influence: 1.5] [Reference Citation Analysis]
97 Björkman K, Sofou K, Darin N, Holme E, Kollberg G, Asin-cayuela J, Holmberg Dahle KM, Oldfors A, Moslemi A, Tulinius M. Broad phenotypic variability in patients with complex I deficiency due to mutations in NDUFS1 and NDUFV1. Mitochondrion 2015;21:33-40. [DOI: 10.1016/j.mito.2015.01.003] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
98 Oldfors A, Tulinius M. Mitochondrial encephalomyopathies. J Neuropathol Exp Neurol 2003;62:217-27. [PMID: 12638726 DOI: 10.1093/jnen/62.3.217] [Cited by in Crossref: 30] [Cited by in F6Publishing: 25] [Article Influence: 1.6] [Reference Citation Analysis]
99 Kwong S, Meyerson C, Zheng W, Kassardjian A, Stanzione N, Zhang K, Wang HL. Acute hepatitis and acute liver failure: Pathologic diagnosis and differential diagnosis. Semin Diagn Pathol 2019;36:404-14. [PMID: 31405537 DOI: 10.1053/j.semdp.2019.07.005] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
100 Diogo L, Grazina M, Garcia P, Rebelo O, Veiga MA, Cuevas J, Vilarinho L, de Almeida IT, Oliveira CR. Pediatric mitochondrial respiratory chain disorders in the Centro region of Portugal. Pediatr Neurol 2009;40:351-6. [PMID: 19380071 DOI: 10.1016/j.pediatrneurol.2008.11.012] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 1.2] [Reference Citation Analysis]
101 Vu TH, Hirano M, Dimauro S. Mitochondrial diseases. Neurologic Clinics 2002;20:809-39. [DOI: 10.1016/s0733-8619(01)00017-2] [Cited by in Crossref: 20] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
102 Wong LJ. Diagnostic challenges of mitochondrial DNA disorders. Mitochondrion 2007;7:45-52. [PMID: 17276740 DOI: 10.1016/j.mito.2006.11.025] [Cited by in Crossref: 49] [Cited by in F6Publishing: 40] [Article Influence: 3.1] [Reference Citation Analysis]
103 Takahashi N, Shimada T, Ishibashi Y, Yoshitomi H, Oyake N, Murakami Y, Nishino I, Nonaka I, Goto Y, Kitamura J. Marked left ventricular hypertrophy in a patient with mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes. Int J Cardiol 2008;129:e77-80. [PMID: 17900719 DOI: 10.1016/j.ijcard.2007.06.123] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
104 Alves CAPF, Teixeira SR, Goncalves FG, Zuccoli G. Neuroimaging Findings in Primary Mitochondrial Cytopathies. In: Mancuso M, Klopstock T, editors. Diagnosis and Management of Mitochondrial Disorders. Cham: Springer International Publishing; 2019. pp. 289-316. [DOI: 10.1007/978-3-030-05517-2_18] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
105 Gerards M, Sallevelt SC, Smeets HJ. Leigh syndrome: Resolving the clinical and genetic heterogeneity paves the way for treatment options. Mol Genet Metab. 2016;117:300-312. [PMID: 26725255 DOI: 10.1016/j.ymgme.2015.12.004] [Cited by in Crossref: 59] [Cited by in F6Publishing: 46] [Article Influence: 8.4] [Reference Citation Analysis]
106 Sofou K, de Coo IFM, Ostergaard E, Isohanni P, Naess K, De Meirleir L, Tzoulis C, Uusimaa J, Lönnqvist T, Bindoff LA, Tulinius M, Darin N. Phenotype-genotype correlations in Leigh syndrome: new insights from a multicentre study of 96 patients. J Med Genet 2018;55:21-7. [PMID: 29101127 DOI: 10.1136/jmedgenet-2017-104891] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 4.4] [Reference Citation Analysis]
107 Dimauro S, Tay S, Mancuso M. Mitochondrial encephalomyopathies: diagnostic approach. Ann N Y Acad Sci 2004;1011:217-31. [PMID: 15126299 DOI: 10.1196/annals.1293.022] [Cited by in Crossref: 31] [Cited by in F6Publishing: 25] [Article Influence: 1.7] [Reference Citation Analysis]
108 Åkebrand R, Andersson S, Seyedi Honarvar AK, Sofou K, Darin N, Tulinius M, Grönlund MA. Ophthalmological characteristics in children with Leigh syndrome - A long-term follow-up. Acta Ophthalmol 2016;94:609-17. [PMID: 26893257 DOI: 10.1111/aos.12983] [Cited by in Crossref: 10] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
109 Leigh PN, Al-Sarraj S, DiMauro S. Impact commentaries. Subacute necrotising encephalomyelopathy (Leigh's disease; Leigh syndrome). J Neurol Neurosurg Psychiatry 2015;86:363-5. [PMID: 25587071 DOI: 10.1136/jnnp-2012-304601] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 1.6] [Reference Citation Analysis]
110 Darin N, Hedberg-Oldfors C, Kroksmark AK, Moslemi AR, Kollberg G, Oldfors A. Benign mitochondrial myopathy with exercise intolerance in a large multigeneration family due to a homoplasmic m.3250T>C mutation in MTTL1. Eur J Neurol 2017;24:587-93. [PMID: 28181352 DOI: 10.1111/ene.13249] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
111 Jeyakumar A, Williamson ME, Brickman TM, Krakovitz P, Parikh S. Otolaryngologic manifestations of mitochondrial cytopathies. Am J Otolaryngol 2009;30:162-5. [PMID: 19410120 DOI: 10.1016/j.amjoto.2008.04.008] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]